{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:08:30Z","timestamp":1788782910658,"version":"build-2803163510"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004241","name":"China Primary Health Care Foundation","doi-asserted-by":"publisher","award":["22992230024"],"award-info":[{"award-number":["22992230024"]}],"id":[{"id":"10.13039\/501100004241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Nutritional Biochemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jnutbio.2026.110475","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:40:23Z","timestamp":1784763623000},"page":"110475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Chebulinic acid restores glycolytic reprogramming and mitochondrial dysfunction in MASLD via modulation of Lp-PLA2 signaling"],"prefix":"10.1016","volume":"158","author":[{"given":"Yinghui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guochun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xicheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingtao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanqing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfeng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jnutbio.2026.110475_bib0001","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41575-022-00635-5","article-title":"Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight","volume":"19","author":"Eslam","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0002","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12916-024-03315-0","article-title":"Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis","volume":"22","author":"Cao","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0003","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1007\/s12072-024-10660-y","article-title":"MAFLD as part of systemic metabolic dysregulation","volume":"18","author":"Zhao","year":"2024","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0004","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s13105-023-00954-4","article-title":"Metabolic dysfunction-associated fatty liver disease (MAFLD): an update of the recent advances in pharmacological treatment","volume":"79","author":"Sangro","year":"2023","journal-title":"J Physiol Biochem"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0005","doi-asserted-by":"crossref","first-page":"5640","DOI":"10.3390\/ijms25115640","article-title":"Metabolic dysfunction-associated steatotic liver disease: from pathogenesis to current therapeutic options","volume":"25","author":"Portincasa","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104451","article-title":"Future potential therapeutics to treat MASH","volume":"30","author":"Mahajan","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0007","doi-asserted-by":"crossref","DOI":"10.1093\/lifemeta\/loae029","article-title":"Potential therapeutic strategies for MASH: from preclinical to clinical development","volume":"3","author":"Xie","year":"2024","journal-title":"Life Metab"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/cells14070471","article-title":"Platelet-activating factor-induced inflammation in obesity: a two-sided coin of protection and risk","volume":"14","author":"Antonopoulou","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0009","first-page":"13","article-title":"Oxidized phospholipids and lipoprotein-associated phospholipase A(2) as important determinants of lp(a) functionality and pathophysiological role","volume":"31","author":"Tselepis","year":"2018","journal-title":"J Biomed Res"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0010","doi-asserted-by":"crossref","unstructured":"Pantazi, D, Tellis, C, and Tselepis, AD JB (2022) Oxidized phospholipids and lipoprotein-associated phospholipase A2 (Lp-PLA2) in atherosclerotic cardiovascular disease: an update. 48, 1257\u20131270.","DOI":"10.1002\/biof.1890"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0011","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.2147\/DMSO.S367483","article-title":"Platelet-activating factor promotes the development of non-alcoholic fatty liver disease","volume":"15","author":"Yin","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0012","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1194\/jlr.R024190","article-title":"Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2","volume":"53","author":"Rosenson","year":"2012","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0013","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.ejim.2014.05.010","article-title":"Unexpected inverse relationship between impaired glucose metabolism and lipoprotein-associated phospholipase A2 activity in patients with stable vascular disease","volume":"25","author":"Mayer","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0014","article-title":"Harnessing nature's pharmacy: investigating natural compounds as novel therapeutics for ulcerative colitis","volume":"15","author":"Huang","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.parkreldis.2023.105799","article-title":"Unveiling Nature's potential: promising natural compounds in Parkinson's disease management","volume":"115","author":"Bhusal","year":"2023","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0016","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1021\/acs.jnatprod.5b00947","article-title":"Feeling Nature's PAINS: natural products, natural product drugs, and pan assay interference compounds (PAINS)","volume":"79","author":"Baell","year":"2016","journal-title":"J Nat Prod"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153479","article-title":"In vivo hepatoprotective activity and the underlying mechanism of chebulinic acid from Terminalia chebula fruit","volume":"83","author":"Feng","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0018","article-title":"Ferroptosis-inhibitory difference between chebulagic acid and chebulinic acid indicates beneficial role of HHDP","volume":"26","author":"Yang","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0019","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.vph.2018.04.005","article-title":"Chebulagic acid chebulinic acid and gallic acid, the active principles of Triphala, inhibit TNF\u03b1 induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38, ERK and NFkB phosphorylation","volume":"108","author":"Shanmuganathan","year":"2018","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0020","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1186\/s13075-020-02370-1","article-title":"Chebulinic acid is a safe and effective antiangiogenic agent in collagen-induced arthritis in mice","volume":"22","author":"Lu","year":"2020","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0021","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1186\/s12906-018-2412-5","article-title":"Chebulinic acid derived from triphala is a promising antitumour agent in human colorectal carcinoma cell lines","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0022","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.mito.2018.07.003","article-title":"Chebulinic acid and boeravinone B act as anti-aging and anti-apoptosis phyto-molecules during oxidative stress","volume":"46","author":"Biradar","year":"2019","journal-title":"Mitochondrion"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0023","first-page":"23","article-title":"Chebulagic acid chebulinic acid and gallic acid, the active principles of Triphala, inhibit tnf\u03b1 induced pro-angiogenic and pro-inflammatory activities in retinal capillary endothelial cells by inhibiting p38","volume":"108","author":"Shanmuganathan","year":"2018","journal-title":"ERK and NFkB phosphorylation"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0024","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/1389200224666230817101950","article-title":"Preclinical pharmacokinetics and CYP modulation activity of chebulinic acid: a potent molecule against metabolic disease","volume":"24","author":"Biswas","year":"2023","journal-title":"Curr Drug Metab"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0025","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.cmet.2024.05.003","article-title":"Metabolic reprogramming in liver fibrosis","volume":"36","author":"Horn","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0026","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1002\/hep.31420","article-title":"From NAFLD to MAFLD: implications of a premature change in terminology","volume":"73","author":"Younossi","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0027","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.apsb.2021.09.019","article-title":"Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma","volume":"12","author":"Du","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.116989","article-title":"Targeted metabolomics for multiple energy metabolites of tricarboxylic acid cycle, glycolysis and oxidative phosphorylation pathway in MAFLD: from analytical method development towards application to authentic samples in mice and human","volume":"265","author":"Fu","year":"2025","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0029","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1476-511X-9-42","article-title":"The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD)","volume":"9","author":"Liu","year":"2010","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0030","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1080\/15548627.2025.2519054","article-title":"Inhibition of lysosomal LAMTOR1 increases autophagy by suppressing the MTORC1 pathway to ameliorate lipid accumulations in MAFLD","volume":"21","author":"Jang","year":"2025","journal-title":"Autophagy"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0031","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1231520","article-title":"Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis","volume":"14","author":"Luo","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0032","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000040273","article-title":"Central role of hypoxia-inducible factor-1\u03b1 in metabolic reprogramming of cancer cells: a review","volume":"103","author":"Zhu","year":"2024","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0033","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3892\/ijmm.2024.5383","article-title":"Role of lactate and lactate metabolism in liver diseases","volume":"54","author":"Yao","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0034","doi-asserted-by":"crossref","first-page":"3350","DOI":"10.1111\/febs.15327","article-title":"Glycolysis - a key player in the inflammatory response","volume":"287","author":"Soto-Heredero","year":"2020","journal-title":"FEBS J"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0035","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/lipd.12191","article-title":"Energy intake and plasma adiponectin as potential determinants of lipoprotein-associated phospholipase A(2) activity: a cross-sectional study","volume":"54","author":"Ntzouvani","year":"2019","journal-title":"Lipids"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0036","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10557-008-6133-8","article-title":"Biology of platelet-activating factor acetylhydrolase (PAF-AH, lipoprotein associated phospholipase A2)","volume":"23","author":"Stafforini","year":"2009","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0037","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/S0022-2275(20)36957-1","article-title":"Plasma cholesteryl ester transfer protein","volume":"34","author":"Tall","year":"1993","journal-title":"J Lipid Res"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0038","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1161\/CIRCRESAHA.110.228742","article-title":"Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2\/PAF acetylhydrolase","volume":"108","author":"Liu","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0039","doi-asserted-by":"crossref","first-page":"25481","DOI":"10.1074\/jbc.270.43.25481","article-title":"Plasma platelet-activating factor acetylhydrolase is a secreted phospholipase A2 with a catalytic triad","volume":"270","author":"Tjoelker","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0040","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1515\/cclm-2013-0358","article-title":"Recent advances in physiological lipoprotein metabolism","volume":"52","author":"Ramasamy","year":"2014","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0041","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bbacli.2017.07.002","article-title":"Antioxidative activity of high-density lipoprotein (HDL): mechanistic insights into potential clinical benefit","volume":"8","author":"Brites","year":"2017","journal-title":"BBA Clin"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0042","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.jacl.2025.11.002","article-title":"Disruption of HDL antioxidant properties in children and adolescents with obesity","volume":"20","author":"Davico","year":"2026","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0043","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1373\/clinchem.2010.155333","article-title":"HDL measures, particle heterogeneity, proposed nomenclature, and relation to atherosclerotic cardiovascular events","volume":"57","author":"Rosenson","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0044","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.freeradbiomed.2025.09.036","article-title":"Activation of the lp-PLA2\/LPC axis triggers endothelial ferroptosis to drive diabetic kidney disease","volume":"241","author":"Zhou","year":"2025","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0045","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/s41423-025-01288-5","article-title":"Targeting Lp-PLA2 inhibits profibrotic monocyte-derived macrophages in silicosis through restoring cardiolipin-mediated mitophagy","volume":"22","author":"Li","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0046","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/s41423-025-01268-9","article-title":"Targeting macrophage polarization by inhibiting Pim2 alleviates inflammatory arthritis via metabolic reprogramming","volume":"22","author":"Xu","year":"2025","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0047","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/s00281-019-00757-0","article-title":"Metabolic reprogramming in osteoclasts","volume":"41","author":"Park-Min","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0048","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.161282","article-title":"Hepatic FASN deficiency differentially affects nonalcoholic fatty liver disease and diabetes in mouse obesity models","volume":"8","author":"Matsukawa","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.120283","article-title":"Saikosaponin C ameliorates renal injury and fibrosis via suppression of the HK2\/PKM2\/LDHA signaling mediated glycolysis in CKD","volume":"353","author":"Deng","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0050","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2012.09.210","article-title":"Lp-PLA2\u2013a novel marker of atherosclerosis: to treat or not to treat?","volume":"165","author":"Tousoulis","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0051","doi-asserted-by":"crossref","DOI":"10.1177\/10760296251360015","article-title":"The value of lp-PLA2 as a biomarker for the diagnosis of plaque stability in atherosclerosis: a meta-analysis","volume":"31","author":"Huang","year":"2025","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0052","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.1038\/srep04905","article-title":"Nitro-oleic acid downregulates lipoprotein-associated phospholipase A2 expression via the p42\/p44 MAPK and NFkappaB pathways","volume":"4","author":"Wang","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0053","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173559","article-title":"Urocortin participates in LPS-induced apoptosis of THP-1 macrophages via S1P-cPLA2 signaling pathway","volume":"887","author":"Zhu","year":"2020","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0054","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.bbrc.2016.07.022","article-title":"Lp-PLA2 silencing protects against ox-LDL-induced oxidative stress and cell apoptosis via Akt\/mTOR signaling pathway in human THP1 macrophages","volume":"477","author":"Zheng","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0055","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.freeradbiomed.2022.11.026","article-title":"Chebulinic acid alleviates LPS-induced inflammatory bone loss by targeting the crosstalk between reactive oxygen species\/NFkappaB signaling in osteoblast cells","volume":"194","author":"Sharma","year":"2023","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0056","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1574892819666230821110429","article-title":"Chebulinic Acid: an incipient anticancer agent","volume":"19","author":"Aashima","year":"2024","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154318","article-title":"Terminalia chebula Retz. Extract ameliorates the symptoms of atopic dermatitis by regulating anti-inflammatory factors in vivo and suppressing STAT1\/3 and NF-kB signaling in vitro","volume":"104","author":"Kim","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0058","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1248\/bpb.34.191","article-title":"Triacylglycerol deposition with group IVC phospholipase A2 expression in oleate- and linoleate-stimulated huh-7 hepatocytes","volume":"34","author":"Ishihara","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0059","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.1038\/s41467-023-41462-9","article-title":"The lipoprotein-associated phospholipase A2 inhibitor Darapladib sensitises cancer cells to ferroptosis by remodelling lipid metabolism","volume":"14","author":"Oh","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0060","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/s41401-021-00703-7","article-title":"Lp-PLA2 inhibition prevents Ang II-induced cardiac inflammation and fibrosis by blocking macrophage NLRP3 inflammasome activation","volume":"42","author":"Lv","year":"2021","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.jnutbio.2026.110475_bib0061","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-008094","article-title":"Inhibiting PLA2G7 reverses the immunosuppressive function of intratumoral macrophages and augments immunotherapy response in hepatocellular carcinoma","volume":"12","author":"Zhang","year":"2024","journal-title":"J Immunother Cancer"}],"container-title":["The Journal of Nutritional Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286326002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955286326002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:20:15Z","timestamp":1788780015000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955286326002172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":61,"alternative-id":["S0955286326002172"],"URL":"https:\/\/doi.org\/10.1016\/j.jnutbio.2026.110475","relation":{},"ISSN":["0955-2863"],"issn-type":[{"value":"0955-2863","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chebulinic acid restores glycolytic reprogramming and mitochondrial dysfunction in MASLD via modulation of Lp-PLA2 signaling","name":"articletitle","label":"Article Title"},{"value":"The Journal of Nutritional Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnutbio.2026.110475","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110475"}}